No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BSX250117P94000
- 0.40
- -0.61-60.40%
15min DelayClose Jan 14 16:00 ET
0.65High0.39Low
0.65Open1.01Pre Close15 Volume120 Open Interest94.00Strike Price759.00Turnover29.86%IV2.14%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.40Extrinsic Value100Contract SizeAmericanOptions Type-0.2402Delta0.1274Gamma273.29Leverage Ratio-0.1472Theta-0.0016Rho-65.64Eff Leverage0.0254Vega
Intraday
- 5D
- Daily
News
CardioFocus Announces Publication of 1-Year ECLIPSE AF Clinical Trial Results
Boston Scientific Expects Farapulse, Watchman to Drive 2025 Growth
Citi Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $107
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
Why Boston Scientific (BSX) Is Skyrocketing in 2025?
Baird Adjusts Price Target on Boston Scientific $104 From $102, Keeps Outperform Rating